Elena Isaevska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elena Isaevska has a total of 190 co-authors. Here are the top co-authors by number of shared publications:
- Maja Popovic
Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Turin, Italy
10 shared publications - Lorenzo Richiardi
Cancer Epidemiology Unit, Department of Medical Sciences, University of Turin and CPO-Piemonte, Turin, Italy
8 shared publications - Franca Rusconi
Department of Mother and Child Health, Azienda USL Toscana Nord Ovest, 56121 Pisa, Italy
6 shared publications - Valentina Fiano
Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, 10126 Turin, Italy
6 shared publications - Charlotte A. M. Cecil
Erasmus Medical Centre, University Medical Center Rotterdam
4 shared publications - Chiara Moccia
Department of Medical Sciences, University of Turin, Torino, Italy
4 shared publications
Latest Publications
- Open Access
DNA methylation as proxy of genetic, prenatal and perinatal psychiatric risk factors
Background: Cord blood DNA methylation profile scores (MPSs) based on genetic and pre-/perinatal risk factors for neurodevelopmental conditions (NDCs) may capture downstream biological effects and help understand how combined exposure signals contribute to NDC risk. Methods: Using data from two longitudinal birth cohorts, Generation R (N train = 1856, N test = 476) and ALSPAC (N validation = 832), we developed cord blood MPSs based on genetic and pre-/perinatal NDC risk factors. We assessed individual and combined predictive performance of risk factors and MPSs for eight childhood psychiatric outcomes (four broad, four specific), measured between ages 5 and 14 years. We also evaluated if the MPSs could be combined into a composite “transmission load” MPS. Results: We validated four novel MPSs: maternal age, birthweight, and genetic liability for ADHD and schizophrenia (r range = 0.08 to 0.29) and included two previously validated MPSs: maternal smoking and gestational age (r range = 0.42 to 0.63). Jointly modeling the six MPSs with their corresponding risk factors explained on average 3.3% of variance in outcomes, higher than that explained by risk factors (1.8%) or MPSs alone (1.6%), indicating complementary sources of risk. The “transmission load” MPS did not replicate due to heterogeneous contributions of the predictors across cohorts. Conclusions: The four novel MPSs based on genetic and pre-/perinatal risk factors can serve as valuable tools for future research. Integrating genetic and prenatal risk factors with DNA methylation at birth can provide insights into their individual and joint contributions to early psychiatric risk and may improve prediction.
Open AccessDNA methylation as proxy of genetic, prenatal and perinatal psychiatric risk factors
Background: Cord blood DNA methylation profile scores (MPSs) based on genetic and pre-/perinatal risk factors for neurodevelopmental conditions (NDCs) may capture downstream biological effects and help understand how combined exposure signals contribute to NDC risk. Methods: Using data from two longitudinal birth cohorts, Generation R (N train = 1856, N test = 476) and ALSPAC (N validation = 832), we developed cord blood MPSs based on genetic and pre-/perinatal NDC risk factors. We assessed individual and combined predictive performance of risk factors and MPSs for eight childhood psychiatric outcomes (four broad, four specific), measured between ages 5 and 14 years. We also evaluated if the MPSs could be combined into a composite “transmission load” MPS. Results: We validated four novel MPSs: maternal age, birthweight, and genetic liability for ADHD and schizophrenia (r range = 0.08 to 0.29) and included two previously validated MPSs: maternal smoking and gestational age (r range = 0.42 to 0.63). Jointly modeling the six MPSs with their corresponding risk factors explained on average 3.3% of variance in outcomes, higher than that explained by risk factors (1.8%) or MPSs alone (1.6%), indicating complementary sources of risk. The “transmission load” MPS did not replicate due to heterogeneous contributions of the predictors across cohorts. Conclusions: The four novel MPSs based on genetic and pre-/perinatal risk factors can serve as valuable tools for future research. Integrating genetic and prenatal risk factors with DNA methylation at birth can provide insights into their individual and joint contributions to early psychiatric risk and may improve prediction.
- Open Access
- 14 April 2026
- Published by Taylor & Francis in Epigenetics
- Vol. 21 (1) , 2654101
Direct and indirect genetic effects of birthweight predisposition on child DNA methylation at birth
Birthweight is a key predictor of infant survival as well as of physical and mental health outcomes across the lifespan [1–4]. Birthweight represents the end result of growth in utero and, therefor...
- 14 April 2026
- Published by Taylor & Francis in Epigenetics
- Vol. 21 (1) , 2654101
Open AccessDirect and indirect genetic effects of birthweight predisposition on child DNA methylation at birth
Birthweight is a key predictor of infant survival as well as of physical and mental health outcomes across the lifespan [1–4]. Birthweight represents the end result of growth in utero and, therefor...
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure from Association Study between Polymorphisms in DNA Methylation–Related Genes and Testicular Germ Cell Tumor Risk
Supplementary Figure from Association Study between Polymorphisms in DNA Methylation–Related Genes and Testicular Germ Cell Tumor Risk
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure from Association Study between Polymorphisms in DNA Methylation–Related Genes and Testicular Germ Cell Tumor Risk
Supplementary Figure from Association Study between Polymorphisms in DNA Methylation–Related Genes and Testicular Germ Cell Tumor Risk
- Open Access
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from Association Study between Polymorphisms in DNA Methylation–Related Genes and Testicular Germ Cell Tumor Risk
Supplementary Data from Association Study between Polymorphisms in DNA Methylation–Related Genes and Testicular Germ Cell Tumor Risk
- 26 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from Association Study between Polymorphisms in DNA Methylation–Related Genes and Testicular Germ Cell Tumor Risk
Supplementary Data from Association Study between Polymorphisms in DNA Methylation–Related Genes and Testicular Germ Cell Tumor Risk
- Open Access
Direct and Indirect Genetic Effects of Birthweight Predisposition on Child DNA Methylation at Birth
Background Birthweight is heritable and strongly associated with epigenetic differences at birth. It is unclear whether a genetic birthweight score is associated with DNA methylation (DNAm) and, if so, whether through direct genetic effects (i.e., child genotype) or indirect genetic effects (i.e., parental genotype, independent of child genotype), which are suspected to be mediated by the prenatal environment (e.g. metabolic factors). Methods We constructed polygenic scores (PGS) for birthweight predisposition in mothers and children using an existing ‘pre-adjusted’ GWAS assessing maternal indirect effects (maternal genotype on offspring birthweight, correcting for offspring genotype) or fetal effects (offspring genotype on offspring birthweight, correcting for maternal genotype) in 2116 families from the Generation R Study. Offspring DNAm levels at 829 birthweight-related sites were then regressed on both maternal and fetal effect PGS. Additionally, we aggregated 829 DNAm sites into a methylation profile score for birthweight (MPS-BW) and tested which pregnancy health factors (n=13) might mediate genetic effects. Findings We identified six DNAm sites associated with maternal indirect effects and the birthweight MPS revealed indirect genetic associations, as well. Gestational age partly mediated maternal indirect effects on DNAm, but no other mediators were identified. Results did not depend on offspring sex. Interpretation This study presents first evidence of maternal genetic effects on offspring birthweight being associated with offspring epigenetic patterns at birth. Paternal genotype was not associated with offspring methylation in this study but was limited by lower sample size and lack of existing GWAS on paternal indirect effects. Funding European Union Evidence before this study Birthweight is a moderately heritable trait and prior genome-wide association studies have identified multiple genetic variants associated with fetal growth. Genetic variants may impact birthweight via direct and indirect genetic routes of transmission. Indirect genetic effects occur when parental genetics still associate with child outcomes independent of genetic transmission to offspring, suggesting involvement of environmental mechanisms. For example, maternal genetic predispositions may shape the intrauterine environment in ways that accelerate or slow fetal growth. Indirect genetic effect may explain up to 22% of birthweight variance. Additionally, epigenetic modifications, particularly differences in DNA methylation (DNAm) at birth, have been linked to birthweight. Recent studies have identified over 900 CpG sites associated with birthweight. However, it is unknown whether the direct and indirect genetic effects on birthweight are reflected in DNAm variation, as well. Added value of this study We found that especially indirect maternal genetic effects on offspring birthweight are associated with offspring DNAm patterns at birth. We have linked six DNAm sites with indirect maternal effects in contrast to only one site with direct genetic transmission. A methylation profile score for birthweight associated similarly with direct and indirect effects, with a trend for stronger association with indirect effects. Implications of all the available evidence The results shed new light on how the interplay between genetics and environment on epigenetics may impact birthweight. This study confirms that maternal genetics partly affect offspring birthweight indirectly, independent of direct transmission. Importantly, our results imply that DNAm levels in cord blood partly reflect these indirect maternal genetic effects. This in turn raises the possibility that DNAm is an important mechanism mediating indirect maternal genetic effects on birthweight, but more research is needed to investigate causality.
Open AccessDirect and Indirect Genetic Effects of Birthweight Predisposition on Child DNA Methylation at Birth
Background Birthweight is heritable and strongly associated with epigenetic differences at birth. It is unclear whether a genetic birthweight score is associated with DNA methylation (DNAm) and, if so, whether through direct genetic effects (i.e., child genotype) or indirect genetic effects (i.e., parental genotype, independent of child genotype), which are suspected to be mediated by the prenatal environment (e.g. metabolic factors). Methods We constructed polygenic scores (PGS) for birthweight predisposition in mothers and children using an existing ‘pre-adjusted’ GWAS assessing maternal indirect effects (maternal genotype on offspring birthweight, correcting for offspring genotype) or fetal effects (offspring genotype on offspring birthweight, correcting for maternal genotype) in 2116 families from the Generation R Study. Offspring DNAm levels at 829 birthweight-related sites were then regressed on both maternal and fetal effect PGS. Additionally, we aggregated 829 DNAm sites into a methylation profile score for birthweight (MPS-BW) and tested which pregnancy health factors (n=13) might mediate genetic effects. Findings We identified six DNAm sites associated with maternal indirect effects and the birthweight MPS revealed indirect genetic associations, as well. Gestational age partly mediated maternal indirect effects on DNAm, but no other mediators were identified. Results did not depend on offspring sex. Interpretation This study presents first evidence of maternal genetic effects on offspring birthweight being associated with offspring epigenetic patterns at birth. Paternal genotype was not associated with offspring methylation in this study but was limited by lower sample size and lack of existing GWAS on paternal indirect effects. Funding European Union Evidence before this study Birthweight is a moderately heritable trait and prior genome-wide association studies have identified multiple genetic variants associated with fetal growth. Genetic variants may impact birthweight via direct and indirect genetic routes of transmission. Indirect genetic effects occur when parental genetics still associate with child outcomes independent of genetic transmission to offspring, suggesting involvement of environmental mechanisms. For example, maternal genetic predispositions may shape the intrauterine environment in ways that accelerate or slow fetal growth. Indirect genetic effect may explain up to 22% of birthweight variance. Additionally, epigenetic modifications, particularly differences in DNA methylation (DNAm) at birth, have been linked to birthweight. Recent studies have identified over 900 CpG sites associated with birthweight. However, it is unknown whether the direct and indirect genetic effects on birthweight are reflected in DNAm variation, as well. Added value of this study We found that especially indirect maternal genetic effects on offspring birthweight are associated with offspring DNAm patterns at birth. We have linked six DNAm sites with indirect maternal effects in contrast to only one site with direct genetic transmission. A methylation profile score for birthweight associated similarly with direct and indirect effects, with a trend for stronger association with indirect effects. Implications of all the available evidence The results shed new light on how the interplay between genetics and environment on epigenetics may impact birthweight. This study confirms that maternal genetics partly affect offspring birthweight indirectly, independent of direct transmission. Importantly, our results imply that DNAm levels in cord blood partly reflect these indirect maternal genetic effects. This in turn raises the possibility that DNAm is an important mechanism mediating indirect maternal genetic effects on birthweight, but more research is needed to investigate causality.
- Open Access
- 29 November 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (48) , eadr2084
Cesarean delivery and blood DNA methylation at birth and childhood: Meta-analysis in the Pregnancy and Childhood Epigenetics Consortium
Children born via cesarean delivery have a higher risk of metabolic, immunological, and neurodevelopmental disorders compared to those born via vaginal delivery, although mechanisms remain unclear. We conducted a meta-analysis of epigenome-wide association studies to examine the associations between delivery mode and blood DNA methylation at birth and its persistence in early childhood. Participants were from 19 pregnancy cohorts (9833 term newborns) and 6 pediatric cohorts (2429 children aged 6 to 10 years). We identified six CpGs in cord blood associated with cesarean delivery (effect size range: 0.4 to 0.7%, P < 1.0 × 10 −7 ): MAP2K2 (cg19423175), LIM2 (cg01500140), CNP (cg13917614), BLM (cg18247172), RASA3 (cg22348356), and RUNX3 (cg20674490), independent of cell proportions and other confounders. In childhood, none of these CpGs were associated with cesarean delivery, and no additional CpGs were identified. Delivery mode was associated with cell proportions at birth but not in childhood. Further research is needed to elucidate cesarean delivery’s molecular influence on offspring health.
- 29 November 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (48) , eadr2084
Open AccessCesarean delivery and blood DNA methylation at birth and childhood: Meta-analysis in the Pregnancy and Childhood Epigenetics Consortium
Children born via cesarean delivery have a higher risk of metabolic, immunological, and neurodevelopmental disorders compared to those born via vaginal delivery, although mechanisms remain unclear. We conducted a meta-analysis of epigenome-wide association studies to examine the associations between delivery mode and blood DNA methylation at birth and its persistence in early childhood. Participants were from 19 pregnancy cohorts (9833 term newborns) and 6 pediatric cohorts (2429 children aged 6 to 10 years). We identified six CpGs in cord blood associated with cesarean delivery (effect size range: 0.4 to 0.7%, P < 1.0 × 10 −7 ): MAP2K2 (cg19423175), LIM2 (cg01500140), CNP (cg13917614), BLM (cg18247172), RASA3 (cg22348356), and RUNX3 (cg20674490), independent of cell proportions and other confounders. In childhood, none of these CpGs were associated with cesarean delivery, and no additional CpGs were identified. Delivery mode was associated with cell proportions at birth but not in childhood. Further research is needed to elucidate cesarean delivery’s molecular influence on offspring health.
- Open Access
- 15 February 2024
- Published by Elsevier in Environmental Research
- Vol. 250, 118496
Examining the relationship between the environmental impact of diet and child growth from a co-benefit perspective
- 15 February 2024
- Published by Elsevier in Environmental Research
- Vol. 250, 118496
Open AccessExamining the relationship between the environmental impact of diet and child growth from a co-benefit perspective
- Open Access
Differences in birth weight between immigrants’ and natives’ children in Europe and Australia: a LifeCycle comparative observational cohort study
Objective Research on adults has identified an immigrant health advantage, known as the ‘immigrant health paradox’, by which migrants exhibit better health outcomes than natives. Is this health advantage transferred from parents to children in the form of higher birth weight relative to children of natives? Setting Western Europe and Australia. Participants We use data from nine birth cohorts participating in the LifeCycle Project, including five studies with large samples of immigrants’ children: Etude Longitudinale Française depuis l’Enfance—France (N=12 494), the Raine Study—Australia (N=2283), Born in Bradford—UK (N=4132), Amsterdam Born Children and their Development study—Netherlands (N=4030) and the Generation R study—Netherlands (N=4877). We include male and female babies born to immigrant and native parents. Primary and secondary outcome measures The primary outcome is birth weight measured in grams. Different specifications were tested: birth weight as a continuous variable including all births (DV1), the same variable but excluding babies born with over 4500 g (DV2), low birth weight as a 0–1 binary variable (1=birth weight below 2500 g) (DV3). Results using these three measures were similar, only results using DV1 are presented. Parental migration status is measured in four categories: both parents natives, both born abroad, only mother born abroad and only father born abroad. Results Two patterns in children’s birth weight by parental migration status emerged: higher birth weight among children of immigrants in France (+12 g, pConclusion The immigrant health advantage is not universally transferred to children in the form of higher birth weight in all host countries. Further research should investigate whether this cross-national variation is due to differences in immigrant communities, social and healthcare contexts across host countries.
Open AccessDifferences in birth weight between immigrants’ and natives’ children in Europe and Australia: a LifeCycle comparative observational cohort study
Objective Research on adults has identified an immigrant health advantage, known as the ‘immigrant health paradox’, by which migrants exhibit better health outcomes than natives. Is this health advantage transferred from parents to children in the form of higher birth weight relative to children of natives? Setting Western Europe and Australia. Participants We use data from nine birth cohorts participating in the LifeCycle Project, including five studies with large samples of immigrants’ children: Etude Longitudinale Française depuis l’Enfance—France (N=12 494), the Raine Study—Australia (N=2283), Born in Bradford—UK (N=4132), Amsterdam Born Children and their Development study—Netherlands (N=4030) and the Generation R study—Netherlands (N=4877). We include male and female babies born to immigrant and native parents. Primary and secondary outcome measures The primary outcome is birth weight measured in grams. Different specifications were tested: birth weight as a continuous variable including all births (DV1), the same variable but excluding babies born with over 4500 g (DV2), low birth weight as a 0–1 binary variable (1=birth weight below 2500 g) (DV3). Results using these three measures were similar, only results using DV1 are presented. Parental migration status is measured in four categories: both parents natives, both born abroad, only mother born abroad and only father born abroad. Results Two patterns in children’s birth weight by parental migration status emerged: higher birth weight among children of immigrants in France (+12 g, pConclusion The immigrant health advantage is not universally transferred to children in the form of higher birth weight in all host countries. Further research should investigate whether this cross-national variation is due to differences in immigrant communities, social and healthcare contexts across host countries.
- Open Access
- 7 March 2023
- Published by Elsevier in Environment International
- Vol. 173, 107864
Modelling socioeconomic position as a driver of the exposome in the first 18 months of life of the NINFEA birth cohort children
- 7 March 2023
- Published by Elsevier in Environment International
- Vol. 173, 107864
Open AccessModelling socioeconomic position as a driver of the exposome in the first 18 months of life of the NINFEA birth cohort children
- 14 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 31 (9) , 1769-1779
Association Study between Polymorphisms in DNA Methylation–Related Genes and Testicular Germ Cell Tumor Risk
Background: Testicular germ cell tumors (TGCT), histologically classified as seminomas and nonseminomas, are believed to arise from primordial gonocytes, with the maturation process blocked when they are subjected to DNA methylation reprogramming. SNPs in DNA methylation machinery and folate-dependent one-carbon metabolism genes have been postulated to influence the proper establishment of DNA methylation. Methods: In this pathway-focused investigation, we evaluated the association between 273 selected tag SNPs from 28 DNA methylation–related genes and TGCT risk. We carried out association analysis at individual SNP and gene-based level using summary statistics from the Genome Wide Association Study meta-analysis recently conducted by the international Testicular Cancer Consortium on 10,156 TGCT cases and 179,683 controls. Results: In individual SNP analyses, seven SNPs, four mapping within MTHFR, were associated with TGCT risk after correction for multiple testing (q ≤ 0.05). Queries of public databases showed that three of these SNPs were associated with MTHFR changes in enzymatic activity (rs1801133) or expression level in testis tissue (rs12121543, rs1476413). Gene-based analyses revealed MTHFR (q = 8.4 × 10–4), methyl-CpG–binding protein 2 (MECP2; q = 2 × 10–3), and ZBTB4 (q = 0.03) as the top TGCT-associated genes. Stratifying by tumor histology, four MTHFR SNPs were associated with seminoma. In gene-based analysis MTHFR was associated with risk of seminoma (q = 2.8 × 10–4), but not with nonseminomatous tumors (q = 0.22). Conclusions: Genetic variants within MTHFR, potentially having an impact on the DNA methylation pattern, are associated with TGCT risk. Impact: This finding suggests that TGCT pathogenesis could be associated with the folate cycle status, and this relation could be partly due to hereditary factors.
- 14 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 31 (9) , 1769-1779
Association Study between Polymorphisms in DNA Methylation–Related Genes and Testicular Germ Cell Tumor Risk
Background: Testicular germ cell tumors (TGCT), histologically classified as seminomas and nonseminomas, are believed to arise from primordial gonocytes, with the maturation process blocked when they are subjected to DNA methylation reprogramming. SNPs in DNA methylation machinery and folate-dependent one-carbon metabolism genes have been postulated to influence the proper establishment of DNA methylation. Methods: In this pathway-focused investigation, we evaluated the association between 273 selected tag SNPs from 28 DNA methylation–related genes and TGCT risk. We carried out association analysis at individual SNP and gene-based level using summary statistics from the Genome Wide Association Study meta-analysis recently conducted by the international Testicular Cancer Consortium on 10,156 TGCT cases and 179,683 controls. Results: In individual SNP analyses, seven SNPs, four mapping within MTHFR, were associated with TGCT risk after correction for multiple testing (q ≤ 0.05). Queries of public databases showed that three of these SNPs were associated with MTHFR changes in enzymatic activity (rs1801133) or expression level in testis tissue (rs12121543, rs1476413). Gene-based analyses revealed MTHFR (q = 8.4 × 10–4), methyl-CpG–binding protein 2 (MECP2; q = 2 × 10–3), and ZBTB4 (q = 0.03) as the top TGCT-associated genes. Stratifying by tumor histology, four MTHFR SNPs were associated with seminoma. In gene-based analysis MTHFR was associated with risk of seminoma (q = 2.8 × 10–4), but not with nonseminomatous tumors (q = 0.22). Conclusions: Genetic variants within MTHFR, potentially having an impact on the DNA methylation pattern, are associated with TGCT risk. Impact: This finding suggests that TGCT pathogenesis could be associated with the folate cycle status, and this relation could be partly due to hereditary factors.